Approach to the patient with leptomeningeal metastases

Jan 3, 2021 by in NEUROLOGY Comments Off on Approach to the patient with leptomeningeal metastases

Introduction Leptomeningeal spread occurs in both solid tumors and hematologic malignancies. Leptomeningeal disease (LMD) for all primary cancer types portends a very poor prognosis, with survival measured in weeks if…

read more

Approach to a patient with brain metastasis

Jan 3, 2021 by in NEUROLOGY Comments Off on Approach to a patient with brain metastasis

Introduction Brain metastases are a frequent occurrence in patients with solid malignancies. Up to 40% of patients with solid tumors will develop brain metastases at some point in their disease…

read more

Approach to the patient with CNS lymphoma

Jan 3, 2021 by in NEUROLOGY Comments Off on Approach to the patient with CNS lymphoma

Introduction Primary central nervous system lymphoma (PCNSL) is defined as lymphoma confined to the central nervous system (CNS) at presentation. By contrast, secondary CNS lymphoma represents a systemic lymphoma (i.e.,…

read more

Approach to the high-grade glioma patient

Jan 3, 2021 by in NEUROLOGY Comments Off on Approach to the high-grade glioma patient

Introduction The broad definition of high-grade glioma encompasses all central nervous system neoplasms that are derived from glial components of the brain and show anaplasia (i.e., poor cellular differentiation, atypia,…

read more

Approach to the low-grade glioma patient

Jan 3, 2021 by in NEUROLOGY Comments Off on Approach to the low-grade glioma patient

Introduction The understanding of low-grade gliomas has significantly changed over the past 10 years. Genomic and epigenetic discoveries have revolutionized our understanding of these cancers. For the first time, the…

read more

Approach to the meningioma patient

Jan 3, 2021 by in NEUROLOGY Comments Off on Approach to the meningioma patient

Introduction Meningiomas are slow-growing extraaxial tumors that account for about 25% of all intracranial tumors. The World Health Organization (WHO) classifies meningiomas as grade I, II, or III based upon…

read more

Evaluation of peripheral nerve lesions

Jan 3, 2021 by in NEUROLOGY Comments Off on Evaluation of peripheral nerve lesions

Disclosures Dr. Ly has no disclosures. Dr. Jordan has research funding from the Department of Defense, the National Institutes of Health, and the Burke Foundation. He receives royalties from Elsevier…

read more

Evaluation of a dural-based lesion

Jan 3, 2021 by in NEUROLOGY Comments Off on Evaluation of a dural-based lesion

Introduction There is significant overlap in the imaging appearance and presentation of dural-based mass lesions. The differential diagnosis includes both benign lesions (such as meningioma—WHO grade I) and more aggressive,…

read more

Imaging of spinal lesions

Jan 3, 2021 by in NEUROLOGY Comments Off on Imaging of spinal lesions

Introduction Spinal cord tumors are uncommon causes of back pain, radicular pain, and sensorimotor deficits in adults and pediatric patients. Primary spinal tumors are less common than intracranial tumors and…

read more

Evaluation of an infratentorial lesion

Jan 3, 2021 by in NEUROLOGY Comments Off on Evaluation of an infratentorial lesion

Introduction The posterior fossa is the infratentorial compartment of the cranial vault, which houses the cerebellum and the bulk of the brainstem. Tumors that occur in this region can arise…

read more
Get Clinical Tree app for offline access